One year continuous run with a totally implantable insulin infusion pump in a human diabetic

Cyclic relationships between diabetic nephropathy and cardiovascular risk factors.

Metabolic syndrome and related disorders·2008

Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.

Diabetes & metabolism·2006

[Inhaled insulin, new perspective for insulin therapy].

Revue medicale de Liege·2005

Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.

Diabetes & metabolism·2004

Effects of dipeptide administration on hypoglycaemic counterregulation in type 1 diabetes.

Diabetes & metabolism·2003

[How I explore...glycemic kinetics by continuous glucose monitoring].

Revue medicale de Liege·2003

Mechanisms of hypersensitivity reactions during hemodialysis.

Transactions - American Society for Artificial Internal Organs·1985

Is the dialysate fluid source of complement activating factors?

Transactions - American Society for Artificial Internal Organs·1985

[Risk Factors for Idiopathic Membranous Nephropathy Complicated by Acute Kidney Injury].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026

Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.

Frontiers in pharmacology·2026

Gaps and disparities in Lp(a) testing before universal screening: A 10-year analysis.

International journal of cardiology. Cardiovascular risk and prevention·2026

Case Report: STAT3 hyper-IgE syndrome in children: two cases report with uncommon complications of tuberculosis and lymphoma.

Frontiers in pediatrics·2026

Elevated IGF-1 levels are associated with accelerated bone age advancement during growth hormone therapy in children: a multicenter cohort study.

Frontiers in endocrinology·2026

Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome.

Haematologica·2026

Related Experiment Videos

One year continuous run with a totally implantable insulin infusion pump in a human diabetic

Related Concept Videos

Cyclic relationships between diabetic nephropathy and cardiovascular risk factors.

Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.

[Inhaled insulin, new perspective for insulin therapy].

Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.

Effects of dipeptide administration on hypoglycaemic counterregulation in type 1 diabetes.

[How I explore...glycemic kinetics by continuous glucose monitoring].

Mechanisms of hypersensitivity reactions during hemodialysis.

Is the dialysate fluid source of complement activating factors?

[Risk Factors for Idiopathic Membranous Nephropathy Complicated by Acute Kidney Injury].

Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.

Gaps and disparities in Lp(a) testing before universal screening: A 10-year analysis.

Case Report: STAT3 hyper-IgE syndrome in children: two cases report with uncommon complications of tuberculosis and lymphoma.

Elevated IGF-1 levels are associated with accelerated bone age advancement during growth hormone therapy in children: a multicenter cohort study.

Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome.

Related Experiment Videos

One year continuous run with a totally implantable insulin infusion pump in a human diabetic

Related Concept Videos

Related Articles